Intracellular Retention of Glycosylphosphatidyl Inositol-Linked Proteins in Caveolin-Deficient Cells

REFERENCES

• Ahmed, S. N., D. A. Brown, and E. London. 1997. On the origin of sphingolipid/cholesterol-rich detergent-insoluble cell membranes: physiological concentrations of cholesterol and sphingolipid induce formation of a detergent-insoluble, liquid-ordered lipid phase in model membranes. Biochemistry 36: 10944–10953.
   PubMed Web of Science ®Google Scholar
• Angst, B. D., C. Marcozzi, and A. Magee. 2001. The cadherin superfamily: diversity in form and function. J. Cell Sci. 114: 629–641.
   PubMed Web of Science ®Google Scholar
• Badizadegan, K., B. L. Dickinson, H. E. Wheeler, R. S. Blumberg, R. K. Holmes, and W. I. Lencer. 2000. Heterogeneity of detergent-insoluble membranes from human intestine containing caveolin-1 and ganglioside G(M1). Am. J. Physiol. Gastroint. Liver Physiol. 278: G895–G904.
   PubMed Web of Science ®Google Scholar
• Bamezai, A., and K. L. Rock. 1991. Effect of ras-activation on the expression of GPI-anchored proteins on the plasma membrane. Oncogene 6: 1445–1451.
   PubMedGoogle Scholar
• Brodsky, R. A., G. L. Mukhina, K. L. Nelson, T. S. Lawrence, R. J. Jones, and J. T. Buckley. 1999. Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin. Blood 93: 1749–1756.
   PubMed Web of Science ®Google Scholar
• Brown, D., and J. K. Rose. 1992. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68: 533–544.
   PubMed Web of Science ®Google Scholar
• Brown, D. A., B. Crise, and J. K. Rose. 1989. Mechanism of membrane anchoring affects polarized expression of two proteins in MDCK cells. Science 245: 1499–1501.
   PubMedGoogle Scholar
• Brown, D. A., and E. London. 1998. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14: 111–136.
   PubMed Web of Science ®Google Scholar
• Brown, D. A., and E. London. 1997. Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes? Biochem. Biophys. Res. Commun. 240: 1–7.
   PubMed Web of Science ®Google Scholar
• Buss, J. E., M. P. Kamps, K. Gould, and B. M. Sefton. 1986. The absence of myristic acid decreases membrane binding of p60src but does not affect tyrosine protein kinase activity. J. Virol. 58: 468–474.
   PubMedGoogle Scholar
• Caras, I. W., G. N. Weddell, M. A. Davitz, V. Nussenzweig, and D. W. Martin, Jr. 1987. Signal for attachment of a phospholipid membrane anchor in decay acelerating factor. Science 238: 1280–1283.
   PubMedGoogle Scholar
• Caras, J. W., G. N. Weddell, and S. R. Williams. 1989. Analysis of the signal for attachment of a glycophospholipid membrane anchor. J. Cell Biol. 108: 1387–1396.
   PubMedGoogle Scholar
• Cavallone, D., N. Malagolini, and F. Serafini-Cessi. 2001. Mechanism of release of urinary Tamm-Horsfall glycoprotein from the kidney GPI-anchored counterpart. Biochem. Biophys. Res. Commun. 280: 110–114.
   PubMedGoogle Scholar
• Couet, J., S. Li, T. Okamoto, P. S. Scherer, and M. P. Lisanti. 1997. Molecular and cellular biology of caveolae: paradoxes and plasticities. Trends Cardiovasc. Med. 7: 103–110.
   PubMedGoogle Scholar
• Das, K., R. Y. Lewis, P. E. Scherer, and M. P. Lisanti. 1999. The membrane spanning domains of caveolins 1 and 2 mediate the formation of caveolin hetero-oligomers. Implications for the assembly of caveolae membranes in vivo. J. Biol. Chem. 274: 18721–18728.
   PubMed Web of Science ®Google Scholar
• Diep, D. B., K. L. Nelson, S. M. Raja, E. N. Pleshak, and J. T. Buckley. 1998. Glycosylphosphatidylinositol anchors of membrane glycoproteins are binding determinants for the channel-forming toxin aerolysin. J. Biol. Chem. 273: 2355–2360.
   PubMed Web of Science ®Google Scholar
• Dietzen, D. J., W. R. Hastings, and D. M. Lublin. 1995. Caveolin is palmitoylated on multiple cysteine residues: palmitoylation is not necessary for localization of caveolin to caveolae. J. Biol. Chem. 270: 6838–6842.
   PubMed Web of Science ®Google Scholar
• Drab, M., P. Verkade, M. Elger, M. Kasper, M. Lohn, B. Lauterbach, J. Menne, C. Lindschau, F. Mende, F. C. Luft, A. Schedl, H. Haller, and T. V. Kurzchalia. 2001. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449–2452.
   PubMed Web of Science ®Google Scholar
• Dupree, P., R. G. Parton, G. Raposo, T. V. Kurzchalia, and K. Simons. 1993. Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J. 12: 1597–1605.
   PubMedGoogle Scholar
• Engelman, J. A., C. C. Wycoff, S. Yasuhara, K. S. Song, T. Okamoto, and M. P. Lisanti. 1997. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J. Biol. Chem. 272: 16374–16381.
   PubMed Web of Science ®Google Scholar
• Engelman, J. A., X. L. Zhang, F. Galbiati, D. Volonte, F. Sotgia, R. G. Pestell, C. Minetti, P. E. Scherer, T. Okamoto, and M. P. Lisanti. 1998. Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer's disease, and muscular dystrophy. Am. J. Hum. Genet. 63: 1578–1587.
   PubMed Web of Science ®Google Scholar
• Engelman, J. A., X. L. Zhang, B. Razani, P. R. G., and M. P. Lisanti. 1999. p42/44 MAP kinase -dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras-MAP kinase and PKA signaling cascades transcriptionally down-regulates caveolin-1 promoter activity. J. Biol. Chem. 274: 32333–32341.
   PubMed Web of Science ®Google Scholar
• Ferguson, M. A. J. 1994. What can GPI do for you. Parasitol. Today 10: 48–52.
   PubMedGoogle Scholar
• Fleming, R. E., E. C. Crouch, C. A. Ruzicka, and W. S. Sly. 1993. Pulmonary carbonic anhydrase IV: developmental regulation and cell-specific expression in the capillary endothelium. Am. J. Physiol. 265: L627–L635.
   Google Scholar
• Fra, A. M., M. Masserini, P. Palestini, S. Sonnino, and K. Simons. 1995. A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface. FEBS Lett. 375: 11–14.
   PubMedGoogle Scholar
• Fra, A. M., E. Williamson, K. Simons, and R. G. Parton. 1995. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc. Natl. Acad. Sci. USA 92: 8655–8659.
   PubMed Web of Science ®Google Scholar
• Fra, A. M., E. Williamson, K. Simons, and R. G. Parton. 1994. Detergent-insoluble glycolipid microdomains in lymphocytes in the absence of caveolae. J. Biol. Chem. 269: 30745–30748.
   PubMed Web of Science ®Google Scholar
• Galbiati, F., J. A. Engelman, D. Volonte, X. L. Zhang, C. Minetti, M. Li, H. J. Hou, B. Kneitz, W. Edelmann, and M. P. Lisanti. 2001. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities. J. Biol. Chem. 276: 21425–21433.
   PubMed Web of Science ®Google Scholar
• Galbiati, F., B. Razani, and M. P. Lisanti. 2001. Emerging themes in lipid rafts and caveolae. Cell 106: 403–411.
   PubMed Web of Science ®Google Scholar
• Galbiati, F., B. Razani, and M. P. Lisanti. 2001. Caveolae and caveolin-3 in muscular dystrophy. Trends Mol. Med. 7: 435–441.
   PubMed Web of Science ®Google Scholar
• Gkantiragas, I., B. Brugger, E. Stuven, D. Kaloyanova, X. Y. Li, K. Lohr, F. Lottspeich, F. T. Wieland, and J. B. Helms. 2001. Sphingomyelin-enriched microdomains at the Golgi Complex. Mol. Biol. Cell. 12: 1819–1833.
   PubMed Web of Science ®Google Scholar
• Hagiwara, Y., T. Sasaoka, K. Araishi, M. Imamura, H. Yorifuji, I. Nonaka, E. Ozawa, and T. Kikuchi. 2000. Caveolin-3 deficiency causes muscle degeneration in mice. Hum. Mol. Genet. 9: 3047–3054.
   PubMed Web of Science ®Google Scholar
• Harris, J. S., D. E. Epps, S. R. Davio, and F. J. Kezdy. 1995. Evidence for transbilayer, tail-to-tail cholesterol dimers in dipalmitoylglycerophosphocholine liposomes. Biochemistry 34: 3851–3857.
   PubMed Web of Science ®Google Scholar
• Henley, J. R., E. W. Krueger, B. J. Oswald, and M. A. McNiven. 1998. Dynamin-mediated internalization of caveolae. J. Cell Biol. 141: 85–99.
   PubMed Web of Science ®Google Scholar
• Ivanyi, D., J. Janssen, and J. G. Collard. 1986. Expression of Ly-6 and Thy-1 antigens on NIH 3T3 cells suppressed after transformation with activated human ras-oncogenes. Int. J. Cancer 38: 575–580.
   PubMedGoogle Scholar
• Koleske, A. J., D. Baltimore, and M. P. Lisanti. 1995. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. USA 92: 1381–1385.
   PubMed Web of Science ®Google Scholar
• Kurzchalia, T., P. Dupree, R. G. Parton, R. Kellner, H. Virta, M. Lehnert, and K. Simons. 1992. VIP 21, A 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. J. Cell Biol. 118: 1003–1014.
   PubMed Web of Science ®Google Scholar
• Lee, H., D. Volonte, F. Galbiati, P. Iyengar, D. M. Lublin, D. B. Bregman, M. T. Wilson, R. Campos-Gonzalez, B. Bouzahzah, R. G. Pestell, P. E. Scherer, and M. P. Lisanti. 2000. Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol. Endocrinol. 14: 1750–1775.
   PubMed Web of Science ®Google Scholar
• Lee, H., S. E. Woodman, J. A. Engelman, D. Volonte', F. Galbiati, H. L. Kaufman, D. M. Lublin, and M. P. Lisanti. 2001. Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase. J. Biol. Chem. 276: 35150–35158.
   PubMed Web of Science ®Google Scholar
• Li, S., J. Couet, and M. P. Lisanti. 1996. Src tyrosine kinases, G alpha subunits and H-Ras share a common membrane-anchored scaffolding protein, Caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J. Biol. Chem. 271: 29182–29190.
   PubMed Web of Science ®Google Scholar
• Li, S., F. Galbiati, D. Volonte, M. Sargiacomo, J. A. Engelman, K. Das, P. E. Scherer, and M. P. Lisanti. 1998. Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes. FEBS Lett. 434: 127–134.
   PubMedGoogle Scholar
• Li, S., K. S. Song, S. S. Koh, A. Kikuchi, and M. P. Lisanti. 1996. Baculovirus-based expression of mammalian caveolin in Sf21 insect cells. A model system for the biochemical and morphological study of caveolar biogenesis. J. Biol. Chem. 271: 28647–28654.
   PubMed Web of Science ®Google Scholar
• Li, S., K. S. Song, and M. P. Lisanti. 1996. Expression and characterization of recombinant caveolin: purification by poly-histidine tagging and cholesterol-dependent incorporation into defined lipid membranes. J. Biol. Chem. 271: 568–573.
   PubMedGoogle Scholar
• Lisanti, M. P., I. W. Caras, M. A. Davitz, and E. Rodriguez-Boulan. 1989. A glycophospholipid membrane anchor acts as an apical targeting signal in polarized epithelial cells. J. Cell Biol. 109: 2145–2156.
   PubMed Web of Science ®Google Scholar
• Lisanti, M. P., I. W. Caras, T. Gilbert, D. Hanzel, and E. Rodriguez-Boulan. 1990. Vectorial apical delivery and slow endocytosis of a glycolipid-anchored fusion protein in transfected MDCK cells. Proc. Natl. Acad. Sci. USA 87: 7419–7423.
   PubMedGoogle Scholar
• Lisanti, M. P., M. C. Field, I. W. Caras, A. K. Menon, and E. Rodriguez-Boulan. 1991. Mannosamine, a novel inhibitor of glycosyl-phosphatidylinositol incorporation into proteins. EMBO J. 10: 1969–1977.
   PubMedGoogle Scholar
• Lisanti, M. P., A. Le Bivic, A. R. Saltiel, and E. Rodriguez-Boulan. 1990. Prefered apical distribution of glycosyl-phosphatidylinositol (GPI) anchored proteins: a highly conserved feature of the polarized epithelial cell phenotype. J. Membr. Biol. 113: 155–167.
   PubMedGoogle Scholar
• Lisanti, M. P., A. Le Bivic, M. Sargiacomo, and E. Rodriguez-Boulan. 1989. Steady-state distribution and biogenesis of endogenous MDCK glycoproteins: evidence for intracellular sorting and polarized cell surface delivery. J. Cell Biol. 109: 2117–2127.
   PubMed Web of Science ®Google Scholar
• Lisanti, M. P., and E. Rodriguez-Boulan. 1990. Glycophospholipid membrane anchoring provides clues to the mechanism of protein sorting in polarized epithelial cells. Trends Biochem. Sci. 15: 113–118.
   PubMedGoogle Scholar
• Lisanti, M. P., E. Rodriguez-Boulan, and A. R. Saltiel. 1990. Emerging functional roles for the glycosyl-phosphatidylinositol (GPI) membrane protein anchor. J. Membr. Biol. 117: 1–10.
   PubMed Web of Science ®Google Scholar
• Lisanti, M. P., M. Sargiacomo, L. Graeve, A. R. Saltiel, and E. Rodriguez-Boulan. 1988. Polarized apical distribution of glycosyl-phosphatidylinositol anchored proteins in a renal epithelial cell line. Proc. Natl. Acad. Sci. USA 85: 9557–9561.
   PubMed Web of Science ®Google Scholar
• Lisanti, M. P., P. Scherer, Z.-L. Tang, and M. Sargiacomo. 1994. Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol. 4: 231–235.
   PubMedGoogle Scholar
• Lisanti, M. P., P. E. Scherer, J. Vidugiriene, Z.-L. Tang, A. Hermanoski-Vosatka, Y.-H. Tu, R. F. Cook, and M. Sargiacomo. 1994. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease. J. Cell Biol. 126: 111–126.
   PubMed Web of Science ®Google Scholar
• Lisanti, M. P., Z.-L. Tang, and M. Sargiacomo. 1993. Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: implications for the biogenesis of caveolae. J. Cell Biol. 123: 595–604.
   PubMed Web of Science ®Google Scholar
• Lisanti, M. P., Z.-T. Tang, P. Scherer, and M. Sargiacomo. 1995. Caveolae purification and GPI-linked protein sorting in polarized epithelia. Methods Enzymol. 250: 655–668.
   PubMedGoogle Scholar
• Monier, S., D. J. Dietzen, W. R. Hastings, D. M. Lublin, and T. V. Kurzchalia. 1996. Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol. FEBS Lett. 388: 143–149.
   PubMedGoogle Scholar
• Monier, S., R. G. Parton, F. Vogel, J. Behlke, A. Henske, and T. Kurzchalia. 1995. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol. Biol. Cell 6: 911–927.
   PubMed Web of Science ®Google Scholar
• Montesano, R., J. Roth, A. Robert, and L. Orci. 1982. Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins. Nature (London) 296: 651–653.
   PubMed Web of Science ®Google Scholar
• Mora, R., V. Bonilha, A. Marmostein, P. E. Scherer, D. Brown, M. P. Lisanti, and E. Rodriguez-Boulan. 1999. Caveolin-2 localizes to the Golgi complex but redistributes to plasma membrane, caveolae, and rafts when co-expressed with caveolin-1. J. Biol. Chem. 274: 25708–25717.
   PubMed Web of Science ®Google Scholar
• Moran, P., H. Raab, W. J. Kohr, and I. W. Caras. 1991. Glycophospholipid membrane anchor attachment: molecular analysis of the cleavage/attachment site. J. Biol. Chem. 266: 1250–1257.
   PubMedGoogle Scholar
• Murata, M., J. Peranen, R. Schreiner, F. Weiland, T. Kurzchalia, and K. Simons. 1995. VIP21/caveolin is a cholesterol-binding protein. Proc. Natl. Acad. Sci. USA 92: 10339–10343.
   PubMed Web of Science ®Google Scholar
• Nelson, K. L., S. M. Raja, and J. T. Buckley. 1997. The glycosylphosphatidylinositol-anchored surface glycoprotein Thy-1 is a receptor for the channel-forming toxin aerolysin. J. Biol. Chem. 272: 12170–12174.
   PubMedGoogle Scholar
• Nichols, B. J., A. K. Kenworthy, R. S. Polishchuk, R. Lodge, T. H. Roberts, K. Hirschberg, R. D. Phair, and J. Lippincott-Schwartz. 2001. Rapid cycling of lipid raft markers between the cell surface and Golgi complex. J. Cell Biol. 153: 529–541.
   PubMed Web of Science ®Google Scholar
• Oh, P., D. P. McIntosh, and J. E. Schnitzer. 1998. Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J. Cell Biol. 141: 101–114.
   PubMed Web of Science ®Google Scholar
• Orlandi, P. A., and P. H. Fishman. 1998. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J. Cell Biol. 141: 905–915.
   PubMed Web of Science ®Google Scholar
• Palade, G. E., and R. R. Bruns. 1968. Structural modification of plasmalemmal vesicles. J. Cell Biol. 37: 633–649.
   PubMed Web of Science ®Google Scholar
• Parolini, I., M. Sargiacomo, F. Galbiati, G. Rizzo, F. Grignani, J. A. Engelman, T. Okamoto, T. Ikezu, P. E. Scherer, R. Mora, E. Rodriguez-Boulan, C. Peschle, and M. P. Lisanti. 1999. Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. J. Biol. Chem. 274: 25718–25725.
   PubMed Web of Science ®Google Scholar
• Parolini, I., M. Sargiacomo, M. P. Lisanti, and C. Peschle. 1996. Signal transduction and GPI-linked proteins (Lyn, Lck, CD4, CD45, G proteins, CD 55) selectively localize in Triton-insoluble plasma membrane domains of human leukemic cell lines and normal granulocytes. Blood 87: 3783–3794.
   PubMed Web of Science ®Google Scholar
• Parton, R. G. 1994. Ultrastructural localization of gangliosides: GM1 is concentrated in caveolae. J. Histochem. Cytochem. 42: 155–166.
   PubMed Web of Science ®Google Scholar
• Parton, R. G., M. Way, N. Zorzi, and E. Stang. 1997. Caveolin-3 associates with developing T-tubules during muscle differentiation. J. Cell Biol. 136: 137–154.
   PubMed Web of Science ®Google Scholar
• Philippova, M. P., V. N. Bochkov, D. V. Stambolsky, V. A. Tkachuk, and T. J. Resink. 1998. T-cadherin and signal-transducing molecules co-localize in caveolin-rich membrane domains of vascular smooth muscle cells. FEBS Lett. 429: 207–210.
   PubMedGoogle Scholar
• Razani, B., J. A. Engelman, X. B. Wang, W. Schubert, X. L. Zhang, C. B. Marks, F. Macaluso, R. G. Russell, M. Li, R. G. Pestell, D. Di Vizio, H. J. Hou, B. Kneitz, G. Lagaud, G. J. Christ, W. Edelmann, and M. P. Lisanti. 2001. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276: 38121–38138.
   PubMedGoogle Scholar
• Razani, B., and M. P. Lisanti. 2001. Caveolin-deficient mice: insights into caveolar function and human disease. J. Clin. Investig. 108: 1553–1561.
   PubMed Web of Science ®Google Scholar
• Rindler, M. J., S. S. Naik, N. Li, T. C. Hoops, and M. N. Peraldi. 1990. Uromodulin (Tamm-Horsfall glycoprotein/uromucoid) is a phosphatidylinositol-linked membrane protein. J. Biol. Chem. 265: 20784–20789.
   PubMed Web of Science ®Google Scholar
• Rothberg, K. G., J. E. Heuser, W. C. Donzell, Y. Ying, J. R. Glenney, and R. G. W. Anderson. 1992. Caveolin, a protein component of caveolae membrane coats. Cell 68: 673–682.
   PubMed Web of Science ®Google Scholar
• Sargiacomo, M., M. P. Lisanti, L. Graeve, A. LeBivic, and E. Rodriguez-Boulan. 1989. Integral and peripheral protein composition of the apical and basolateral membrane domains in MDCK cells. J. Membr. Biol. 107: 277–286.
   PubMed Web of Science ®Google Scholar
• Sargiacomo, M., P. E. Scherer, Z.-L. Tang, E. Kubler, K. S. Song, M. C. Sanders, and M. P. Lisanti. 1995. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc. Natl. Acad. Sci. USA 92: 9407–9411.
   PubMedGoogle Scholar
• Sargiacomo, M., M. Sudol, Z.-L. Tang, and M. P. Lisanti. 1993. Signal transducing molecules and GPI-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J. Cell Biol. 122: 789–807.
   PubMed Web of Science ®Google Scholar
• Scheiffele, P., P. Verkade, A. M. Fra, H. Virta, K. Simons, and E. Ikonen. 1998. Caveolin-1 and -2 in the exocytic pathway of MDCK cells. J. Cell Biol. 140: 795–806.
   PubMed Web of Science ®Google Scholar
• Scherer, P. E., G. Z. Lederkremer, S. Williams, M. Fogliano, G. Baldini, and H. F. Lodish. 1996. Cab45, a novel (Ca2+)-binding protein localized to the Golgi lumen. J. Cell Biol. 133: 257–268.
   PubMedGoogle Scholar
• Scherer, P. E., R. Y. Lewis, D. Volonte, J. A. Engelman, F. Galbiati, J. Couet, D. S. Kohtz, E. van Donselaar, P. Peters, and M. P. Lisanti. 1997. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem. 272: 29337–29346.
   PubMed Web of Science ®Google Scholar
• Scherer, P. E., T. Okamoto, M. Chun, I. Nishimoto, H. F. Lodish, and M. P. Lisanti. 1996. Identification, sequence and expression of caveolin-2 defines a caveolin gene family. Proc. Natl. Acad. Sci. USA 93: 131–135.
   PubMed Web of Science ®Google Scholar
• Scherer, P. E., Z.-L. Tang, M. C. Chun, M. Sargiacomo, H. F. Lodish, and M. P. Lisanti. 1995. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution: identification and epitope mapping of an isoform-specific monoclonal antibody probe. J. Biol. Chem. 270: 16395–16401.
   PubMed Web of Science ®Google Scholar
• Schubert, W., P. G. Frank, B. Razani, D. Park, C.-W. Chow, and M. P. Lisanti. 2001. Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J. Biol. Chem. 276: 48619–48622.
   PubMed Web of Science ®Google Scholar
• Shogomori, H., and A. H. Futerman. 2001. Cholera toxin is found in detergent-insoluble rafts/domains at the cell surface of hippocampal neurons but is internalized via a raft-independent mechanism. J. Biol. Chem. 276: 9182–9188.
   PubMedGoogle Scholar
• Simionescu, N. 1983. Cellular aspects of transcapillary exchange. Physiol. Rev. 63: 1536–1560.
   PubMed Web of Science ®Google Scholar
• Smart, E. J., G. A. Graf, M. A. McNiven, W. C. Sessa, J. A. Engelman, P. E. Scherer, T. Okamoto, and M. P. Lisanti. 1999. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 19: 7289–7304.
   PubMed Web of Science ®Google Scholar
• Song, K. S., M. Sargiacomo, F. Galbiati, M. Parenti, and M. P. Lisanti. 1997. Targeting of a G alpha subunit (Gi1 alpha) and c-Src tyrosine kinase to caveolae membranes: clarifying the role of N-myristoylation. Cell. Mol. Biol. (Noisy-Le-Grand) 43: 293–303.
   PubMedGoogle Scholar
• Song, K. S., P. E. Scherer, Z.-L. Tang, T. Okamoto, S. Li, M. Chafel, C. Chu, D. S. Kohtz, and M. P. Lisanti. 1996. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J. Biol. Chem. 271: 15160–15165.
   PubMed Web of Science ®Google Scholar
• Song, K. S., Z.-L. Tang, S. Li, and M. P. Lisanti. 1997. Mutational analysis of the properties of caveolin-1. A novel role for the C-terminal domain in mediating homotypic caveolin-caveolin interactions. J. Biol. Chem. 272: 4398–4403.
   PubMed Web of Science ®Google Scholar
• Soole, K. L., M. A. Jepson, G. P. Hazlewood, H. J. Gilbert, and B. H. Hirst. 1995. Epithelial sorting of a glycosylphosphatidylinositol-anchored bacterial protein expressed in polarized renal MDCK and intestinal Caco-2 cells. J. Cell Sci. 108: 369–377.
   PubMedGoogle Scholar
• Tang, Z.-L., P. E. Scherer, T. Okamoto, K. Song, C. Chu, D. S. Kohtz, I. Nishimoto, H. F. Lodish, and M. P. Lisanti. 1996. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J. Biol. Chem. 271: 2255–2261.
   PubMed Web of Science ®Google Scholar
• Torgersen, M. L., G. Skretting, B. van Deurs, and K. Sandvig. 2001. Internalization of cholera toxin by different endocytic mechanisms. J. Cell Sci. 114: 3737–3747.
   PubMed Web of Science ®Google Scholar
• Uittenbogaard, A., and E. J. Smart. 2000. Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation, and rapid transport of cholesterol to caveolae. J. Biol. Chem. 275: 25595–25599.
   PubMedGoogle Scholar
• Yamada, E. 1955. The fine structure of the gall bladder epithelium of the mouse. J. Biophys. Biochem. Cytol. 1: 445–458.
   PubMedGoogle Scholar